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Comparision of Controlled Pressure Belt -Allowing Mobility- with Sandbags
After Percutaneous Coronary Intervention: Pilot Study
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Aım: Investigation of the efﬁcacy and safety of belt mechanism (anjiyobelt) that
which we developed recently and have taken the patent of it, allows mobility after
coronary operations, causes to apply adjustable pressure to the femoral artery
Methods: Between October 2012 and April 2013, 191 consecutive patients under-
going percutan coronary intervention electively or due to acute coronary syndrome
were enrolled. There are 96 patients in sandbags group and 93 patients in anjiobelt
group. Manual compression applied to the femoral artery until reaching to primary
homeostasis. Then 4-5 kilograms of sandbags or anjiobelt placed. Mobilization was
allowed in case of need in anjiobelt group. 24 hours after the procedure, bruises
superﬁcial femoral region and hematoma, pseudo-aneurysm, arteriovenous ﬁstula
complications of femoral artery with Doppler ultrasound were noted.
Results: Hematoma occurred more frequently in Sandbag group. Less than 1 cm
hematoma developed in 52 patients with sandbags and in 25 patients with anjiobelt
(p<0.0001). 1-5 cm sized hematoma also developed in 5 patients with sandbags and in
3 patients with anjiobelt (p<0.0001). Femoral artery pseudoaneurysm was seen in 4
patients. One of these two patients was used anjiobelt, other two patients was used
sandbags (p¼0.975).
Conclusion: Anjiyobelt signiﬁcantly reduces the incidence of hematoma according to
conventional sandbags in patients undergoing PCI. Other complications of femoral
region in terms of efﬁciency and safety appears to be similar to the sand bags. The
absolute immobilization of the main problems of these patients have been eliminated
by anjiyobelt.P
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Inﬂammation and Nitrosative Stress in Patients With Type 2 Diabetes: A
Randomized, Double-Blind, Placebo-Controlled Trial
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Objectıve: Tocotrienols (T3) were neglected in the past, today get attentions due to
their antioxidant and none-antioxidant activity. The objective of this study was to
evaluate the effects of the daily intake of 200 mg T3 added in canola oil over 8 weeks
on microalbuminuria, inﬂammation and nitrosative stress in type 2 diabetic patients.
Methods: This study was a double-blinded, placebo-controlled, randomized trial. A total
of 50 patients with T2DM and FBS >126 mg/dl treated by non-insulin hypoglycemic
drugs were randomly assigned to receive either 15 ml T3 enriched canola oil (200mg/day
T3) or pure canola oil for 8 weeks. Urine microalbumin, volume and Creatinine levels,
Serum hs-CRP, and nitric oxide (NO) levels were measured before and after intervention.
Results: From 50 subjects participated in this study 44 completed the study. There
were no signiﬁcant differences in baseline characteristics, dietary intake and physical
activity between groups. Urine microalbumin and serum hs-CRP were declined
signiﬁcantly in T3 treated group. At the end of the study, patients who treated with T3
had lower Urine microalbumin (11 (9, 25) vs. 22(15, 39.75) nmol/dl, p¼0.003) and
hs-CRP changes (-10/9115/5vs. -9/8827/5 Pg/ml, p¼0.048) than control group. A
non-signiﬁcant decrease was also observed in serum NO level in T3 treated group with
no changes in urine volume and creatinine levels.
Conclusıon: These ﬁndings indicate that T3 leads to ameliorate proteinuria and can
protect the kidney against inﬂammation (hs-CRP) and nitrosative stress (NO).JACC Vol 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/POSTPP-374
The Impact of Transcatheter Aortic Valve Implantation on Pulmonary
Hypertension
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Background and AIM: Pulmonary hypertension (PH) commonly co-exists with
severe aortic stenosis (AS). This co-existence increases operative mortality of the
patients. The relationship between transcatheter aortic valve implantation (TAVI) and
PH is not established in the literature. The aim of this study is to examine the feasi-
bility of TAVI, which has been performed successfully to risky and inoperable
patients in recent years, on the patients with PH and also the effect of TAVI on PH.
Methods-Results: Seventy patients were performed TAVI between July 2011 and
December 2012. Of these 70 patients, 51 were female and 19 were male with a 77,6
years mean age. Before the operation, the patients were divided into three groups
according to systolic pulmonary artery pressure (sPAP). The groups were determined
as follows: group 1 sPAP < 40 mmHg, group 2 sPAP 40-59 mmHg, group 3 sPAP
>60 mmHg. Seventy percent of the patients were in the group 2 and 3. After TAVI,
sPAP of group 2 and 3 statistically decreased (group 2; 47,44,6 and 36,66,3
p<0,0001; group 3; 64,54,7 and 43,29,2 p<0,001, before and after TAVI
respectively) and while this statistically signiﬁcant decrease lasted for 6 months in
group 2 (p:0,006), it lasted without being statistically signiﬁcant (p:0,07) in group 3
after the ﬁrst month (64,54,7 and 40,88,0 p:0.001). While the statistically
signiﬁcant difference between the sPAP of groups before the operation continued after
the TAVI (p:<0,0001) and the ﬁrst month following (p:0,02), no statistically signif-
icant difference was determined in the 6th month (p:0,06).
Conclusıon: With this study we have shown that treatment of aortic stenosis with
TAVI; ﬁrstly it can be performed successfully and safely in the PH group with high
sPAP, and secondly applying TAVI decreases sPAP signiﬁcantly and that it is
a constant decrease.ERS C229
